Loading...

  1. v1.11.0Android
    • Improved language and localization support
    • Bug fixes
  2. v1.15.0iOS
    • Improved language and localization support
    • Time picker control updated to support iOS 18 and above
  3. v1.14.0iOS
    We’ve made several updates to improve your experience with My Clinical Diary:
    • Added support for uploading files and images to diary questions in V2 Zelta studies
    • Enabled Zelta V2 study agent accounts to access the app
    • Refreshed branding with the Zelta logo on the splash and login screens
    • Resolved minor usability issues and made small bug fixes
  4. v1.13.0iOS
    * Support for Zelta V2 Participants: My Clinical Diary now supports Zelta V2 study participants, providing seamless access through the embedded responsive web page viewer.
    * iPad Optimization: The app is now fully optimized to fit larger iPad screens for a better user experience.
    * UI and Defect Fixes: Additional minor UI changes and defect fixes to enhance performance and usability.
  5. v1.12.0iOS
    - Improved user experience when re-engaging the app after it goes into the background, including when using biometric authentication (FaceID, TouchID)
    - Zelta Privacy statement has been updated, and made more easily available via app
    - Minor defect fixes
  6. v1.11.1iOS
    Multiple bug fixes
  7. v1.11.0iOS
    - Participant Agent account logins to support eObsRO: We've added the capability for Participant Agent account logins to support eObsRO via the app.
    - Minor UI improvements: We've made some minor UI improvements to improve usability.
    - iOS 15+ support: We've leveraged modern iOS frameworks to ensure the app works seamlessly on devices running iOS 15 or higher. Please note that devices running iOS 14 or older will no longer be supported.
  8. v1.10.0iOS
    The IBM Clinical Development platform is now Merative Clinical Development (https://www.merative.com/clinical-development). Clinical trial participants using the My Clinical Diary app will continue to use the same login credentials to interact with the clinical trial, and submit study diaries and questionnaires without disruption. Minor changes to the app have been made as the brand changes from IBM to Merative (https://www.merative.com/). The same features and functions remain, and study participants will have the same user experience.
    
    Additional minor changes include:
    
     - Issue resolved where re-authentication after logging out occasionally failed
     - On-boarding screens for setting security questions have been combined into a single screen
  9. v1.9.0iOS
    • Supports a database designer option to display the web based My Clinical Diary application inside a viewer of the My Clinical Diary mobile app. App users with this option enabled will submit diaries via the embedded web based user interface.
    • Web viewer interface makes available the eConsent module, if the study is using it.
  10. v1.8.0iOS
    • Updated login screen
    • Added support for dark mode
  11. v1.7.0iOS
    • Support for iOS 13
  12. v1.6.0iOS
    • The app is now translated in 30 additional languages for your comfort.
    • Based on your device configuration, the app will be displayed in your preferred language.
  13. v1.5.0iOS
    • Data privacy policy update.
    • Face ID support.
    • General bug fixes.
  14. v1.4.0iOS
    • Improved app multi-tasking functionality and session management.
    • Localized language translations for application menu and prompts.
    • General bug fixes.
  15. v1.3iOS
    The App has been renamed IBM My Clinical Diary
  16. v1.2iOS
    International language support and localization
    Bug fixes

Disclosure: Independent intel to help mobile builders succeed.

AI-powered analysis with editorial review, built from publicly available sources. Marlvel.ai is not affiliated with, endorsed by, or sponsored by Merative My Clinical Diary, its developer, the app publisher, Apple, or Google Play. All trademarks, logos, and screenshots referenced remain the property of their respective owners.

Data licensed under CC-BY-NC 4.0